Etonogestrel

DRUG6 trials

Sponsors

Organon and Co, University of Pittsburgh, University of Campinas, Brazil, Assiut University, University of New Mexico

Conditions

Benign Prostatic Hyperplasia (BPH)ContraceptionEndometriosisHIVSystemic Lupus Erythematosus

Phase 2

A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)

TerminatedNCT00651807

Organon and CoBenign Prostatic Hyperplasia (BPH)

Start: 2008-03-01End: 2008-08-01Updated: 2026-04-08

Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus

Sixth Affiliated Hospital, Sun Yat-sen UniversitySystemic Lupus Erythematosus

Start: 2023-04-01End: 2025-10-31Target: 180Updated: 2023-03-30

Phase 4

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

CompletedNCT02082652

University of PittsburghContraception, HIV

Start: 2014-10-31End: 2016-03-31Updated: 2017-09-14

Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis

CompletedNCT02480647

University of Campinas, BrazilEndometriosis

Start: 2016-05-31End: 2017-08-31Updated: 2017-08-14

Breastfeeding Etonogestrel Implant Study

CompletedNCT03978598

University of New MexicoContraception

Start: 2019-06-03End: 2024-09-19Updated: 2025-11-28

Unknown Phase

Abnormal Uterine Bleeding and Progestin-only Contraceptives

CompletedNCT03398811

Assiut UniversityContraception

Start: 2018-08-01End: 2020-11-01Updated: 2020-12-17

Related Papers

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART

Journal of Antimicrobial Chemotherapy2019-07-0218 citations

Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.

2018-11-0159 citations